electroCore, Inc.
electroCore, Inc. (Nasdaq: ECOR) is a bioelectronic technology company that develops and sells personal-use prescription medical devices and consumer products for general wellness and human performance. Its prescription products include gammaCore, a handheld, non-invasive vagus nerve stimulation device cleared for… From the company’s description.
Over the twelve months to Sep 30, 2026, electroCore, Inc. reported revenue of $37.97M, up 27.3% from a year earlier, and a net loss of $12.70M. Its operating margin was −33.1%, and operations used $10.89M in cash. In fiscal 2025, it reported revenue of $32.03M, up 27.2% from fiscal 2024, and a net loss of $13.97M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What electroCore, Inc. does
In the company’s own words
electroCore, Inc. (Nasdaq: ECOR) is a bioelectronic technology company that develops and sells personal-use prescription medical devices and consumer products for general wellness and human performance. Its prescription products include gammaCore, a handheld, non-invasive vagus nerve stimulation device cleared for several primary headache conditions, and Quell Fibromyalgia, a wearable neuromodulation device for reducing fibromyalgia symptoms in adults with high pain sensitivity. Consumer products include Truvaga wellness handsets and TAC-STIM devices for human performance, sold to active-duty military and professional organizations. Quell over-the-counter products are no longer commercially available, though replacement electrodes remain on sale. The company sells in the United States and select international markets, with major customers including the U.S. Department of Veterans Affairs and the U.K. National Health Service; the VA accounted for 71.2% of revenue in 2025. electroCore includes its wholly owned subsidiary NeuroMetrix and employed 83 full-time employees as of February 1, 2026.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- ROCKAWAY, NJ
- Fiscal year end
- December
- CIK
- 1560258
- SIC
- 3845
Financial performance, year by year
Fiscal 2018–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns electroCore, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · electroCore, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do electroCore, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of electroCore, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in electroCore, Inc.'s last four quarterly filings that the numbers alone won't show?”